These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 15853588
21. Editorial review: targets for glioma treatment: from bench to bedside. Sanson M. Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046 [Abstract] [Full Text] [Related]
22. Promising new therapies for malignant gliomas. Fine HA. Cancer J; 2007 Nov; 13(6):349-54. PubMed ID: 18032970 [Abstract] [Full Text] [Related]
23. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
24. Cell surface receptors in malignant glioma. Li YM, Hall WA. Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029 [Abstract] [Full Text] [Related]
25. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model. Tran TT, Uhl M, Ma JY, Janssen L, Sriram V, Aulwurm S, Kerr I, Lam A, Webb HK, Kapoun AM, Kizer DE, McEnroe G, Hart B, Axon J, Murphy A, Chakravarty S, Dugar S, Protter AA, Higgins LS, Wick W, Weller M, Wong DH. Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330 [Abstract] [Full Text] [Related]
26. Drug delivery strategies for the treatment of malignant gliomas. Allhenn D, Boushehri MA, Lamprecht A. Int J Pharm; 2012 Oct 15; 436(1-2):299-310. PubMed ID: 22721856 [Abstract] [Full Text] [Related]
27. Editorial: what is new in the treatment of gliomas? Omuro AM, Delattre JY. Curr Opin Neurol; 2007 Dec 15; 20(6):704-7. PubMed ID: 17992093 [Abstract] [Full Text] [Related]
28. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Chakravarti A, Dicker A, Mehta M. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):927-31. PubMed ID: 14967452 [Abstract] [Full Text] [Related]
29. Update on the therapeutic approaches to brain tumors. Lallana EC, Abrey LE. Expert Rev Anticancer Ther; 2003 Oct 01; 3(5):655-70. PubMed ID: 14599089 [Abstract] [Full Text] [Related]
30. The role of growth factors in central nervous system tumours. Nieder C, Schlegel J, Andratschke N, Thamm R, Grosu AL, Molls M. Anticancer Res; 2003 Oct 01; 23(2C):1681-6. PubMed ID: 12820440 [Abstract] [Full Text] [Related]
37. A comprehensive outlook on intracerebral therapy of malignant gliomas. Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S, Sampson JH. Crit Rev Oncol Hematol; 2011 Oct 01; 80(1):54-68. PubMed ID: 20888252 [Abstract] [Full Text] [Related]
38. Developing new methods for the treatment of malignant brain tumours: local delivery of anti-neoplastic agents using biodegradable polymers. Olivi A, DiMeco F, Bohan E, Brem H. Forum (Genova); 2000 Oct 01; 10(2):152-65. PubMed ID: 10875976 [Abstract] [Full Text] [Related]
39. Basis and results of chemotherapeutic treatment of gliomas. Crafts DC, Wilson CB. Bull Cancer; 1977 Oct 01; 64(1):101-14. PubMed ID: 861384 [Abstract] [Full Text] [Related]
40. Brainstem gliomas in children and adults. Laigle-Donadey F, Doz F, Delattre JY. Curr Opin Oncol; 2008 Nov 01; 20(6):662-7. PubMed ID: 18841048 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]